Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
17
IVP Quote, Financials, Valuation and Earnings
Last price:
$0.04
Seasonality move
:
-74.59%
Day range:
$0.04 - $0.04
52-week range:
$0.04 - $5.96
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.01x
P/B ratio:
0.38x
Volume:
22.1M
Avg. volume:
77.1M
1-year change:
-99.14%
Market cap:
$1.6M
Revenue:
$16.6M
EPS (TTM):
-$4.41
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Inspire Veterinary Partners, Inc. has -- downside to fair value with a price target of -- per share.
IVP vs. S&P 500
-
Over the past 5 trading days, Inspire Veterinary Partners, Inc. has underperformed the S&P 500 by -21.08% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Inspire Veterinary Partners, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Inspire Veterinary Partners, Inc. has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Inspire Veterinary Partners, Inc. reported revenues of $4.3M.
Earnings Growth
-
Inspire Veterinary Partners, Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Inspire Veterinary Partners, Inc. reported earnings per share of -$0.41.
Enterprise value:
15.8M
EV / Invested capital:
0.74x
Price / LTM sales:
0.01x
EV / EBIT:
--
EV / Revenue:
1.01x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-3.64x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$1.9M
Return On Assets:
-55.28%
Net Income Margin (TTM):
-76.75%
Return On Equity:
-489.01%
Return On Invested Capital:
-62.59%
Operating Margin:
-45.58%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $16.1M | $17.1M | $15.6M | $4M | $4.3M | |
| Gross Profit | $2.9M | $1.5M | $1.9M | $285.9K | $456.5K | |
| Operating Income | -$5.9M | -$8.8M | -$9M | -$2.7M | -$2M | |
| EBITDA | -$4.6M | -$7.1M | -$7.6M | -$2.4M | -$1.6M | |
| Diluted EPS | -$166.83 | -$149.70 | -$4.41 | -$0.38 | -$0.41 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | $3.5M | $4.5M | $3.8M | |
| Total Assets | -- | -- | $21.3M | $22.4M | $24M | |
| Current Liabilities | -- | -- | $5.1M | $7M | $9.7M | |
| Total Liabilities | -- | -- | $18.6M | $19.4M | $19.8M | |
| Total Equity | -- | -- | $2.7M | $3M | $4.2M | |
| Total Debt | -- | -- | $14.7M | $13.7M | $13.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$3.4M | -$10.1M | -$4.2M | -$6.3M | -$1.3M | |
| Cash From Investing | -$6M | -$1.7M | -$2M | -$25.5K | -$43.5K | |
| Cash From Financing | $11.2M | $10.7M | $5.9M | $7M | $1.5M | |
| Free Cash Flow | $5.1M | -$10.3M | -$4.3M | -$6.3M | -$1.3M | |
IVP
Sector
Market Cap
$1.6M
$28M
Price % of 52-Week High
0.63%
51.03%
Dividend Yield
0%
0%
Shareholder Yield
-137.53%
-1.54%
1-Year Price Total Return
-99.14%
-17.48%
Beta (5-Year)
--
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.05
200-day SMA
Sell
Level
$1.08
Bollinger Bands (100)
Sell
Level
0.33 - 1.05
Chaikin Money Flow
Sell
Level
-717.8M
20-day SMA
Sell
Level
$0.08
Relative Strength Index (RSI14)
Sell
Level
18.15
ADX Line
Sell
Level
48.72
Williams %R
Buy
Level
-96.7391
50-day SMA
Sell
Level
$0.46
MACD (12, 26)
Sell
Level
-0.11
25-day Aroon Oscillator
Sell
Level
-80
On Balance Volume
Neutral
Level
228.9M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-3.4214)
Sell
CA Score
(Annual)
Level (-4.3924)
Buy
Beneish M-Score
(Annual)
Level (-3.0797)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (8.4103)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Inspire Veterinary Partners, Inc. engages in the business of operating small animal general practice hospitals which serve all manner of companion pets, emphasizing canine, and feline breeds and including equine care. The firm is also involved in acquiring additional veterinary hospitals including general practice, mixed animal facilities, and critical and emergency care. The company was founded on December 2, 2020 and is headquartered in Virginia Beach, VA.
Stock Forecast FAQ
In the current month, IVP has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The IVP average analyst price target in the past 3 months is --.
-
Where Will Inspire Veterinary Partners, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Inspire Veterinary Partners, Inc. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Inspire Veterinary Partners, Inc.?
Analysts are divided on their view about Inspire Veterinary Partners, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Inspire Veterinary Partners, Inc. is a Sell and believe this share price will rise from its current level to --.
-
What Is Inspire Veterinary Partners, Inc.'s Price Target?
The price target for Inspire Veterinary Partners, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is IVP A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Inspire Veterinary Partners, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of IVP?
You can purchase shares of Inspire Veterinary Partners, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Inspire Veterinary Partners, Inc. shares.
-
What Is The Inspire Veterinary Partners, Inc. Share Price Today?
Inspire Veterinary Partners, Inc. was last trading at $0.04 per share. This represents the most recent stock quote for Inspire Veterinary Partners, Inc.. Yesterday, Inspire Veterinary Partners, Inc. closed at $0.04 per share.
-
How To Buy Inspire Veterinary Partners, Inc. Stock Online?
In order to purchase Inspire Veterinary Partners, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get IVP Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
IVP
Sector
P/E ratio
--
23.89x
PEG ratio
0.00x
-0.01x
P/B ratio
0.38x
1.82x
Price / LTM sales
0.01x
1.60x
Growth Metrics
IVP
Sector
Revenue growth
6.6%
4.62%
Earnings growth
-7.82%
10.88%
Revenue (5-year growth)
--
6.5%
Earnings forecast
--
-$0.21
Profitability
IVP
Sector
Profitability FY 2024
$2M
$3.5M
Return on invested capital
-62.59%
-31.77%
Return on assets
-55.28%
-27.96%
Return on equity
-489.01%
-37.63%
Earnings Date
Last Earnings Date
Dec
26
Next Earnings Date
Dec
26
Estimated Next Earnings Date
Mar
27
Balance Sheet
IVP
Sector
Total cash
$2.9M
$26.3M
Short term investments
--
$25.7M
Total assets
$20.2M
$78M
Long term debt
$13.5M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
